selegiline has been researched along with Brain Ischemia in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 11 (61.11) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmari, M; Gharbavi, M; Hosseini, MJ; Jafari-Anarkoli, I; Mahmoudi, J; Sharafi, A | 1 |
| Ahmadi, R; Amini-Khoei, H; Bagheri, N; Mobini, GR; Mokhtari, T; Sabzevary-Ghahfarokhi, M; Saghaei, E | 1 |
| Abdelsalam, RM; Atia, AS; Seif-El-Nasr, M | 1 |
| Magyar, K; Nagy, Z; Simon, L; Szilágyi, G; Wappler, E | 1 |
| Feng, JJ; Li, C; Wu, YP; Zhang, GY | 1 |
| Johansson, BB | 1 |
| Aráujo, DT; Cunha, GM; Maia, FD; Pitombeira, BS; Viana, GS | 1 |
| Ann, HS; Jang, KJ; Jhoo, JH; Jhoo, WK; Kim, HC; Kim, WK; Kim, YS; Kwon, YS; Nabeshima, T; Shin, EJ; Wie, MB | 1 |
| Krieglstein, J; Schilling, M; Semkova, I; Wolz, P | 1 |
| Ballabriga, J; Ferrer, I; Pellisé, A | 1 |
| Ekblom, J; Garpenstrand, H; Oreland, L; Prince, JA; Tottmar, O | 1 |
| Ekblom, J; Oreland, L; Tottmar, O | 1 |
| Arányi, P; Baranyi, A; Erdö, F; Takács, J | 1 |
| Haapalinna, A; Jolkkonen, J; Kuhmonen, J; Sivenius, J | 1 |
| Haapalinna, A; Jolkkonen, J; Kauppinen, R; Nyman, L; Sivenius, J | 1 |
| Haapalinna, A; Jolkkonen, J; Puurunen, K; Sirviö, J; Sivenius, J | 1 |
| Bolay, H; Dalkara, T; Gürsoy-Ozdemir, Y; Saribaş, O; Söylemezoglu, F; Unal, I | 1 |
| Bori, Z; Nagy, Z; Orbay, P; Simon, L; Szilágyi, G | 1 |
1 review(s) available for selegiline and Brain Ischemia
| Article | Year |
|---|---|
Environmental influence on recovery after brain lesions--experimental and clinical data.
Topics: Animals; Brain Ischemia; Cerebral Cortex; Dendrites; Environment; Humans; Motor Activity; Neuronal Plasticity; Neuroprotective Agents; Pyramidal Cells; Rats; Selegiline; Stem Cell Transplantation | 2003 |
17 other study(ies) available for selegiline and Brain Ischemia
| Article | Year |
|---|---|
Selegiline (L-Deprenyl) Mitigated Oxidative Stress, Cognitive Abnormalities, and Histopathological Change in Rats: Alternative Therapy in Transient Global Ischemia.
Topics: Animals; Antioxidants; Brain; Brain Ischemia; Cognition; Male; Neuroprotective Agents; Oxidative Stress; Rats; Rats, Wistar; Selegiline | 2020 |
Possible involvement of PI3K/AKT/mTOR signaling pathway in the protective effect of selegiline (deprenyl) against memory impairment following ischemia reperfusion in rat.
Topics: Animals; Brain Ischemia; Hippocampus; Male; Maze Learning; Memory; Memory Disorders; Neurons; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Selegiline; Signal Transduction; TOR Serine-Threonine Kinases | 2019 |
Effect of MAO-B inhibition against ischemia-induced oxidative stress in the rat brain. Comparison with a rational antioxidant.
Topics: Animals; Antioxidants; beta Carotene; Brain Chemistry; Brain Ischemia; Catalase; Dose-Response Relationship, Drug; L-Lactate Dehydrogenase; Male; Malondialdehyde; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurons; Norepinephrine; Oxidative Stress; Rats; Rats, Wistar; Reperfusion Injury; Selegiline; Superoxide Dismutase | 2008 |
(-)Deprenyl-N-oxide, a (-)deprenyl metabolite, is cytoprotective after hypoxic injury in PC12 cells, or after transient brain ischemia in gerbils.
Topics: Animals; Apoptosis; Brain Ischemia; Carotid Artery Diseases; Cell Death; Cell Hypoxia; Gerbillinae; Hippocampus; Mitochondrial Membranes; Neurons; Neuroprotective Agents; PC12 Cells; Rats; Reactive Oxygen Species; Selegiline; Time Factors | 2009 |
Cerebral ischemia-reperfusion induces GAPDH S-nitrosylation and nuclear translocation.
Topics: Active Transport, Cell Nucleus; Analysis of Variance; Animals; Apoptosis; Brain Ischemia; CA1 Region, Hippocampal; Cell Nucleus; Dizocilpine Maleate; Enzyme Inhibitors; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Indazoles; Male; Monoamine Oxidase; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase Type I; Nitroso Compounds; Nuclear Proteins; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Selegiline; Ubiquitin-Protein Ligases; Vitamin B 12 | 2012 |
l-Deprenyl prevents lipid peroxidation and memory deficits produced by cerebral ischemia in rats.
Topics: Animals; Antioxidants; Avoidance Learning; Brain Ischemia; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Lipid Peroxidation; Maze Learning; Memory Disorders; Motor Activity; Neuroprotective Agents; Nitrites; Rats; Rats, Wistar; Selegiline; Thiobarbituric Acid Reactive Substances | 2004 |
Selegiline potentiates the effects of EGb 761 in response to ischemic brain injury.
Topics: Animals; Brain; Brain Ischemia; Drug Synergism; Gerbillinae; Ginkgo biloba; Male; Mice; Mice, Inbred BALB C; Motor Activity; Plant Extracts; Reactive Oxygen Species; Selegiline | 2004 |
Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage.
Topics: Animals; Animals, Newborn; Astrocytes; Brain Ischemia; Cells, Cultured; Cerebral Cortex; Glutamic Acid; Hippocampus; Immunohistochemistry; Male; Mice; Nerve Growth Factors; Neurons; Neuroprotective Agents; Rats; Rats, Inbred F344; RNA, Messenger; Selegiline | 1996 |
L-Deprenyl does not reduce brain damage in global forebrain ischemia in adult gerbils (Meriones ungiculatus).
Topics: Age Factors; Animals; Brain Ischemia; Cell Death; Gerbillinae; Neuroprotective Agents; Prosencephalon; Pyramidal Cells; Reperfusion Injury; Selegiline | 1997 |
A cell culture model of cerebral ischemia as a convenient system to screen for neuroprotective drugs.
Topics: Animals; Benzophenones; Brain Ischemia; Catechol O-Methyltransferase Inhibitors; Cell Survival; Cells, Cultured; Embryo, Mammalian; Enzyme Inhibitors; L-Lactate Dehydrogenase; Models, Neurological; Monoamine Oxidase Inhibitors; Neurons; Neuroprotective Agents; Nitrophenols; Prosencephalon; Rats; Rats, Sprague-Dawley; Selegiline; Time Factors; Tolcapone | 1998 |
Cytoprotection by deprenyl and tolcapone in a cell culture model of cerebral ischaemia.
Topics: Animals; Benzophenones; Brain Ischemia; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Cell Hypoxia; Cells, Cultured; Cytoprotection; Drug Combinations; Female; Hypoglycemia; In Situ Nick-End Labeling; L-Lactate Dehydrogenase; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Nitrophenols; Pregnancy; Prosencephalon; Rats; Rats, Sprague-Dawley; Selegiline; Tolcapone | 1998 |
Different neurorescue profiles of selegiline and p-fluoro-selegiline in gerbils.
Topics: Animals; Brain Ischemia; Cell Survival; Dose-Response Relationship, Drug; Fluorine Compounds; Gerbillinae; Hippocampus; Male; Nerve Degeneration; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Pyramidal Cells; Reperfusion Injury; Selegiline | 2000 |
The neuroprotective effects of (-)deprenyl in the gerbil hippocampus following transient global ischemia.
Topics: Animals; Brain Ischemia; Cell Death; Female; Gerbillinae; Hippocampus; Monoamine Oxidase Inhibitors; Pyramidal Cells; Selegiline | 2000 |
MAO-B inhibition by a single dose of l-deprenyl or lazabemide does not prevent neuronal damage following focal cerebral ischaemia in rats.
Topics: Animals; Brain; Brain Ischemia; Cerebral Infarction; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurons; Picolinic Acids; Rats; Rats, Wistar; Selegiline | 2000 |
Selegiline combined with enriched-environment housing attenuates spatial learning deficits following focal cerebral ischemia in rats.
Topics: Animals; Behavior, Animal; Brain; Brain Ischemia; Disease Models, Animal; Drug Administration Schedule; Environment; Forelimb; Housing, Animal; Male; Maze Learning; Motor Activity; Rats; Rats, Wistar; Selegiline; Spatial Behavior | 2001 |
Chronic daily administration of selegiline and EGb 761 increases brain's resistance to ischemia in mice.
Topics: Actins; Animals; Apoptosis; Brain; Brain Ischemia; Caspases; Cerebral Infarction; Drug Administration Schedule; Ginkgo biloba; Immunity, Innate; In Situ Nick-End Labeling; Mice; Neurons; Neuroprotective Agents; Plant Extracts; Selegiline | 2001 |
(-)-D-Deprenyl attenuates apoptosis in experimental brain ischaemia.
Topics: Animals; Apoptosis; Brain Infarction; Brain Ischemia; Electrocoagulation; GAP-43 Protein; Gene Expression Regulation; In Situ Nick-End Labeling; Neuroprotective Agents; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; RNA, Messenger; Selegiline; Temporal Lobe | 2001 |